|
Sparano J.A., Vrdoljak E., Rixe O., Xu B., Manikhas A., Medina C., Da Costa S.C.V., Ro J., Rubio G., Rondinon M., Manga G.P., Peck R., Poulart V., Conte P. Randomized Phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. Journal of Clinical Oncology. 10 July 2010. 28:3256-3263. 10.1200/JCO.2009.24.4244
AÑO: 2010; IF: 18.97
|
20530276
|
Marti S, Galan FM, Casero JM, Merino J, Rubio G. Characterization of trisomic natural killer cell abnormalities in a patient with constitutional trisomy 8 mosaicism. Pediatr Hematol Oncol. 2008 Mar;25(2):135-46. doi: 10.1080/08880010801890135. PubMed PMID: 18363181.
AÑO: 2008; IF: 1.2
|
|
Rubio G, Ferez X, Mora A, Galvez J, Chicano A, Garcia-Penarrubia P. Beta1 integrin triggering affects leukemic cell line sensitivity to natural killer cells. Cancer Immunol Immunother. 2002 May;51(3):130-8. doi: 10.1007/s00262-002-0264-8. Epub 2002 Feb 28. PubMed PMID: 11941451.
AÑO: 2002; IF: 6.63
|
|
Garcia-Penarrubia P, Lorenzo N, Galvez J, Campos A, Ferez X, Rubio G. Study of the physical meaning of the binding parameters involved in effector-target conjugation using monoclonal antibodies against adhesion molecules and cholera toxin. Cell Immunol. 2002 Feb;215(2):141-50. doi: 10.1016/s0008-8749(02)00023-0. PubMed PMID: 12202151.
AÑO: 2002; IF: 4.178
|
|
Cabrera L, Galvez J, Lajarin F, Rubio G, Aparicio P, Garcia-Penarrubia P. Conjugation between cloned human NK cells (H7.8) and K562/MOLT4 tumor cell systems: saturability, binding parameters, and population distribution of conjugates. Cell Immunol. 1996 Apr 10;169(1):133-41. doi: 10.1006/cimm.1996.0101. PubMed PMID: 8612286.
AÑO: 1996; IF: 3.7
|